GovWire

Consultation outcome: Consultation on a new Code of Practice for the Expert Advisory Committees

Commission On Human Medicines

September 8
13:31 2022

Code of practice

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email webupdates@mhra.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Detail of outcome

A consultation document which summarises the proposals to improve and strengthen the Code of Practice for experts who provide advice on which decisions about the regulation of medicines and medical devices are based, to ensure that experts providing the advice are independent and impartial, and that the processes in place to manage conflicts of interest are robust and clear to all, was posted on the GOV.UK website on 8 September 2022. The deadline for comments was 24 May 2022.

Original consultation

Summary

We are consulting on a set of proposals to improve and strengthen the Code of Practice for experts who provide advice on which decisions about the regulation of medicines and medical devices are based, to ensure that experts providing the advice are independent and impartial, and that the processes in place to manage conflicts of interest are robust and clear to all.

This consultation ran from
to

Consultation description

Through the proposals outlined in this consultation we aim to:

  • Actively manage conflicts of interest and associated issues of gifts, hospitality, other payments and influence
  • Proactively support individuals to ensure that they know what is and is not acceptable to prevent wrongdoing from occurring
  • Provide the public with accessible information so that they can see what is happening and, where appropriate, ask questions
  • Take firm and decisive action when individual wrongdoing is discovered including where appropriate, disciplinary action

The proposed changes also seek to encourage greater inclusion of patient and their representatives in advisory committee discussions, so that individuals with lived and personal experience can contribute to discussions more easily.

We look forward to receiving views on these proposals from all interested parties patients, manufacturers and suppliers, researchers, developers, clinicians, other healthcare professionals and the wider public - to allow us to review them further and refine them so that they reflect best practice.

We invite you to respond to our questions here.

This consultation will run for six weeks, from 12 April until 24 May 2022.

Documents

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: